‘Epigenetic Engineering’ Gene Therapy From Epic Bio Shows Early Promise

Progress For Non-Cutting CRISPR Technology

 
• By Andrew McConaghie

The San Francisco-based company has taken a step forward with proof of concept for its ‘switch on or switch off’ approach to gene regulation via non-cutting CRISPR molecules.

DNA
Epic Bio is focused on epigenetics - turning on or off existing genes, rather than editing or replacing them as with other approaches. • Source: Shutterstock

More from Neurological

More from Therapy Areas